Laparoscopic Kasai Has Similar Anesthetic Outcomes to Open Kasai
Launched by TAICHUNG VETERANS GENERAL HOSPITAL · Nov 30, 2023
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
Biliary atresia is (BA) a rare biliary tree disease. This disease, which is usually found in infancy is characterized by biliary inflammation and obliteration. The incidence variate from 1 in 5000 to 20000. However, high prevalence rate up to 1 in 5-10,000 was comparatively noted in eastern Asia, especially in Japan and Taiwan. Biliary atresia can be treated by "Kasai operation" ( Kasai portoenterotomy) or liver transplantation. In the previous study, 60% of biliary atresia patients after receiving Kasai portoenterostomy could have better liver prognosis.The timing of Kasai operation is als...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children who had undergone Kasai portoenterostomy between January 2011 and December 2021
- Exclusion Criteria:
- • severe congenital heart disease requiring surgical treatment,
- • reoperation,
- • a diagnosis of non-biliary atresia,
- • incomplete medical records.
About Taichung Veterans General Hospital
Taichung Veterans General Hospital is a leading medical institution in Taiwan, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to facilitate the development of new therapies and improve patient outcomes. With a focus on patient-centered care and adherence to rigorous ethical standards, Taichung Veterans General Hospital plays a pivotal role in bridging the gap between research and clinical practice, fostering collaborations that contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported